Bionano Genomics, Inc. — Director's Dealing 2019

Oct 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2019-10-23

Reporting Person: TWOMEY CHRISTOPHER J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-23	Common Stock	A	9500	$0.85	Acquired	19500	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-23	Common Stock Warrants (right to buy)	$0.86	A	9500	Acquired	2024-10-23	Common Stock (9500)	Indirect

Footnotes

F1: Acquired from the Issuer pursuant to an Underwriting Agreement dated October 21, 2019 with a closing date of October 23, 2019. The Underwriting Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.

F2: The total per share and accompanying common warrant price offered in the public offering is $0.86. Each share of common stock is being sold together with a common warrant to purchase one share of the Company's common stock. The public offering price, per share is $0.85 and per common warrant is $0.01.